|

DC05F01 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Heronova Pharmaceuticals1

Indications

  • Solid Tumors1
  • Ovarian Cancer1
  • Small Cell Lung Cancer1
  • Lung Cancer1
  • Cancer1

Other1 trial

A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.